Early research (Phase 1)Study completedNCT01209039What this trial is testingA Repeat Dose Positron Emission Tomography Study With GSK1144814Who this might be right forSchizophrenia GlaxoSmithKline 41
Not applicableNot Yet RecruitingNCT07454200What this trial is testingFeasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for SchizophreniaWho this might be right forSCHIZOPHRENIA 1 (Disorder)Hospitalized Adult Patients The Hashemite University 36
Not applicableEnded earlyNCT05961163What this trial is testingChronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational StudyWho this might be right forCoronary DiseaseMyocardial InfarctionHeart Failure+13 more Universitätsklinikum Hamburg-Eppendorf 61
Early research (Phase 1)Study completedNCT03356639What this trial is testingAssess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With SchizophreniaWho this might be right forSchizophrenia Astellas Pharma Global Development, Inc. 32
Post-approval studies (Phase 4)Ended earlyNCT03643159What this trial is testingA Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive DisorderWho this might be right forSchizophreniaBipolar 1 DisorderMajor Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2
Early research (Phase 1)Study completedNCT02748694What this trial is testingPhase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics StudyWho this might be right forHealthy VolunteersSchizophrenia Neurocrine Biosciences 114
Early research (Phase 1)Study completedNCT02804568What this trial is testingSafety Study in Adults With SchizophreniaWho this might be right forSchizophrenia Alkermes, Inc. 42
Not applicableStudy completedNCT07757750What this trial is testingSimulation-Based Schizophrenia Training in Nursing EducationWho this might be right forSCHIZOPHRENIA 1 (Disorder)Simulation Based LearningNursing Students Medipol University 105
Early research (Phase 1)Study completedNCT02320032What this trial is testingAn Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaWho this might be right forSchizophrenia Alkermes, Inc. 140
Early research (Phase 1)Ended earlyNCT02566759What this trial is testingA TAK-831-1001, Single and Multiple Rising Dose Study in Healthy ParticipantsWho this might be right forSchizophrenia, Cerebellar Ataxia Neurocrine Biosciences 110
Early research (Phase 1)Study completedNCT06253546What this trial is testingSafety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaWho this might be right forSchizophrenia Teva Branded Pharmaceutical Products R&D LLC 24
Large-scale testing (Phase 3)Study completedNCT01720095What this trial is testingNiapsan as Add -on Therapy to Antipsychotic Treatment in First Episode PsychosisWho this might be right forPsychosis Nova Scotia Health Authority 22
Early research (Phase 1)Study completedNCT01429740What this trial is testingThe Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy AdultsWho this might be right forSchizophrenia Pfizer 29
Not applicableLooking for participantsNCT07716969What this trial is testingTOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated PsychosisWho this might be right forPsychosisSchizo Affective DisorderSCHIZOPHRENIA 1 (Disorder) Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 250
Early research (Phase 1)Study completedNCT02567370What this trial is testingSingle-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581Who this might be right forSchizophrenia or Schizoaffective Disorder Amgen 70
Early research (Phase 1)Study completedNCT01620060What this trial is testingLurasidone Pediatric Pharmacokinetics StudyWho this might be right forSchizophreniaAutism Sumitomo Pharma America, Inc. 105
Early research (Phase 1)Study completedNCT00945503What this trial is testingPositron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.Who this might be right forSchizophrenia GlaxoSmithKline 12
Early research (Phase 1)Not Yet RecruitingNCT06980207What this trial is testingA Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017Who this might be right forHallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia Luye Pharma Group Ltd. 40
Not applicableUnknownNCT00717509What this trial is testingAssociation of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in SchizophreniaWho this might be right forSchizophreniaMetabolic SyndromeGenetic Polymorphism Seoul National Hospital 150
Testing effectiveness (Phase 2)Study completedNCT04030143What this trial is testingA Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 DisorderWho this might be right forSchizophreniaBipolar I Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 266